ArticleMolecular therapy. Methods & clinical development2025

Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors?

Steven J GrayPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.